Algorithm

U.S. Air Force Secretary Kendall Flies in AI-piloted X-62A VISTA

Retrieved on: 
Friday, May 3, 2024
Aircraft, AIR, DARPA, ACE, Society, Architecture, LMT, Certification, AI, SACS, Software, Lockheed Martin, Artificial intelligence, VISTA, Aviation, MFA, Lockheed, Government, Algorithm, Simulation, Defense, Skunk Works, Jet fuel

EDWARDS AIR FORCE BASE, Calif., May 3, 2024  /PRNewswire/ -- Lockheed Martin Skunk Works® (NYSE: LMT) joined the U.S. Air Force Test Pilot School and other government and industry partners in hosting U.S. Secretary of the Air Force Frank Kendall to fly in the X-62A Variable In-flight Simulation Test Aircraft (VISTA), a one-of-a-kind aircraft modified to test artificial intelligence (AI) and autonomy capabilities.

Key Points: 
  • EDWARDS AIR FORCE BASE, Calif., May 3, 2024 /PRNewswire/ -- Lockheed Martin Skunk Works® (NYSE: LMT) joined the U.S. Air Force Test Pilot School and other government and industry partners in hosting U.S. Secretary of the Air Force Frank Kendall to fly in the X-62A Variable In-flight Simulation Test Aircraft (VISTA), a one-of-a-kind aircraft modified to test artificial intelligence (AI) and autonomy capabilities.
  • VISTA is an AI pathfinder that facilitates development and testing of cutting-edge AI techniques with new uncrewed vehicle designs.
  • "Our proven hardware and software architecture enable safe and controlled environments for AI agents and advanced algorithms to rapidly prototype and develop."
  • This architecture has proven to be reliable and robust enough to transition into third-party distributed hardware to replicate safe and controlled flight test objectives as demonstrated by VISTA.

Computer Vision in Healthcare Market Worth $11.5 billion | MarketsandMarkets™

Retrieved on: 
Friday, May 3, 2024
Cloud, Computer vision, AMD, Pulse, Investment, Personal computer, Hospital, SOC, Xilinx, SenseTime, Accident, Healthcare industry, Omniverse, Research, Intel, Growth, Patient safety, Computer, Microsoft, Market development, Legal Entity Identifier, Region, Magnetic reluctance, Patient, Acquisition, Nvidia, Caregiver, NVIDIA, Thermo Fisher Scientific, Azure, Ageing, Government, Algorithm, Health, Retail

"The largest share in the computer vision in healthcare market, based on type, was attributed to the PC-based computer vision systems segment in 2023."

Key Points: 
  • "The largest share in the computer vision in healthcare market, based on type, was attributed to the PC-based computer vision systems segment in 2023."
  • The PC-based computer vision systems segment holds the largest market share in the computer vision in healthcare market in 2023.
  • The patient activity monitoring/fall prevention segment is expected to experience the highest growth in the computer vision in healthcare market.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the computer vision in healthcare market.

Computer Vision in Healthcare Market Worth $11.5 billion | MarketsandMarkets™

Retrieved on: 
Friday, May 3, 2024
Cloud, Computer vision, AMD, Pulse, Investment, Personal computer, Hospital, SOC, Xilinx, SenseTime, Accident, Healthcare industry, Omniverse, Research, Intel, Growth, Patient safety, Computer, Microsoft, Market development, Legal Entity Identifier, Region, Magnetic reluctance, Patient, Acquisition, Nvidia, Caregiver, NVIDIA, Thermo Fisher Scientific, Azure, Ageing, Government, Algorithm, Health, Retail

"The largest share in the computer vision in healthcare market, based on type, was attributed to the PC-based computer vision systems segment in 2023."

Key Points: 
  • "The largest share in the computer vision in healthcare market, based on type, was attributed to the PC-based computer vision systems segment in 2023."
  • The PC-based computer vision systems segment holds the largest market share in the computer vision in healthcare market in 2023.
  • The patient activity monitoring/fall prevention segment is expected to experience the highest growth in the computer vision in healthcare market.
  • Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the computer vision in healthcare market.

Johnson & Johnson Highlights Commitment to Transform Treatment of Retinal Diseases at ARVO 2024

Retrieved on: 
Friday, May 3, 2024
AMD, Patient, Abstract (summary), Research, Johnson & Johnson, Collection, Paratriathlon, Abstract, Development, Genetic testing, Retina, Algorithm, Geographic atrophy, Diagnosis, Biomarker, Annual general meeting, ARVO, IRD, Pharmaceutical industry

RARITAN, N.J., May 3, 2024 /PRNewswire/ -- Johnson & Johnson today announced that eight company-sponsored presentations will be featured during the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting taking place in Seattle from May 5–9, 2024. The Company's two oral presentations will include one highlighting a real-world analysis on the economic value of early genetic testing in patients with inherited retinal diseases (IRDs), a group of rare eye disorders that can lead to serious vision impairment (Abstract #2154), and the second evaluating the role of automatic deep-learning based algorithms to measure precursors of geographic atrophy (GA), a late-stage and severe form of age-related macular degeneration (AMD) (Abstract #2770).1,2

Key Points: 
  • Johnson & Johnson to debut first-of-its-kind EYE-RD Global Registry, aiming to bridge knowledge gaps for inherited retinal diseases
    RARITAN, N.J., May 3, 2024 /PRNewswire/ -- Johnson & Johnson today announced that eight company-sponsored presentations will be featured during the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting taking place in Seattle from May 5–9, 2024.
  • "At Johnson & Johnson, we are committed to preserving vision, harnessing the best science to find solutions for those living with blinding retinal diseases," said Hideo Makimura, M.D., Ph.D., Vice President and Global Head, Specialty Ophthalmology Research and Development, Johnson & Johnson Innovative Medicine.
  • "These data at ARVO 2024 showcase our commitment to bringing innovative new therapies that preserve and restore vision for patients worldwide."
  • A complete listing of the Company-sponsored abstracts being featured at the ARVO Annual Meeting is provided below.

UMC Passes Historic Changes for our LGBTQ+ Family

Retrieved on: 
Thursday, May 2, 2024
Education, United Methodist Church, Courage, Pacific School of Religion, Language, Human, Spirituality, Protestantism, Dignity, Policy, Research, UMC, LGBTQ, PSR, U.N, Gender studies, Methodist Church, Multimedia, Associate, Queer, Social justice, Algorithm, Organization, Person, Nursing

BERKELEY, Calif., May 2, 2024 /PRNewswire/ -- This week, the United Methodist Church (UMC) excised discriminatory policies against LGBTQ+ persons, many of which have been a part of its rules since 1972. While this is a celebration for those inside the denomination, it's also a victory for champions of dignity and human rights everywhere. The UMC is the second-largest Protestant denomination in the U.S., with a global membership of 10 million. With this change, it becomes one of few, and one of the largest, worldwide Protestant bodies without anti-LGBTQ positions.

Key Points: 
  • The UMC is the second-largest Protestant denomination in the U.S., with a global membership of 10 million.
  • With this change, it becomes one of few, and one of the largest, worldwide Protestant bodies without anti-LGBTQ positions.
  • This change in UMC policy has been labored for by many, some of whom contributed decades of work but didn't live to see this day.
  • At PSR, our vision is to create a world where all can thrive, and are grateful to be partners with the UMC at this historic moment.

Oracle Database 23ai Brings the Power of AI to Enterprise Data and Applications

Retrieved on: 
Thursday, May 2, 2024
Cloud, Goldengate, Organization, RAFT, JSON, NRI, Risk, AI, Oracle Cloud, ISO, RAG, Serverless computing, DBT Online Inc., REST, Algorithm, Nomura Research Institute, Oracle Application Express, Machine learning, OCI, Database, IDC, SQL, Oracle Database, Information technology

AUSTIN, Texas, May 2, 2024 /PRNewswire/ -- Oracle Database 23ai, the latest release of Oracle's converged database, is now generally available as a broad range of cloud services. This long-term support release includes Oracle AI Vector Search and more than 300 additional major features focused on simplifying the use of AI with data, accelerating app development, and running mission-critical workloads. The new AI Vector Search capabilities enable customers to securely combine search for documents, images, and other unstructured data with search on private business data, without moving or duplicating it. Oracle Database 23ai brings AI algorithms to where the data lives, instead of having to move the data to where the AI algorithm lives. This allows AI to run in real-time in Oracle databases, and greatly improves the effectiveness, efficiency, and security of AI.

Key Points: 
  • Oracle Database 23ai brings AI algorithms to where the data lives, instead of having to move the data to where the AI algorithm lives.
  • Oracle Database 23ai is available in Oracle Cloud Infrastructure (OCI) on Oracle Exadata Database Service, Oracle Exadata Cloud@Customer and Oracle Base Database Service, as well as on Oracle Database@Azure.
  • "Oracle Database 23ai is a game changer for enterprises worldwide, and because of the importance of the breakthrough AI technology in this release, we are renaming it to Oracle Database 23ai," said Juan Loaiza, executive vice president, Mission-Critical Database Technologies, Oracle.
  • Oracle Database 23ai aims to solve this problem by enabling the coordination of vectors with customer's data using AI Vector Search.

Inthority launches simplified email-based tracking solution for busy professionals

Retrieved on: 
Thursday, May 2, 2024
Entrepreneurship, BCC, CRM, Algorithm, Lawyer, Workflow, Risk, Loss, Strategic planning, Sales

VIENNA, Va., May 2, 2024 /PRNewswire-PRWeb/ -- Inthority.com has launched an email-based referral tracking solution for busy professionals. Its founding team explains.

Key Points: 
  • Inthority.com has launched an email-based tracking solution for busy professionals.
  • With Inthority professionals can eliminate data entry by simply BCC-ing [email protected] on any email they wish to track.
  • VIENNA, Va., May 2, 2024 /PRNewswire-PRWeb/ -- Inthority.com has launched an email-based referral tracking solution for busy professionals.
  • "Our email-based tracking solution is a game-changer for busy professionals.

AISAP Raises $13 Million in Seed Funding for First AI-Powered, Point Of Care Ultrasound Diagnostic Solution

Retrieved on: 
Thursday, May 2, 2024
Emergency department, Mayo Clinic, Deep learning, Jefferson Health, TEL, Mossad, Death, Cyber, Life, Intelligence, Sheba Medical Center, Echocardiography, IDL, Patient, POCUS, Financial services, Diagnosis, Internal medicine, Algorithm, Ultrasound, Medical imaging

TEL AVIV, Israel, May 2, 2024 /PRNewswire/ --  AISAP, whose AI-powered Point Of Care Assisted Diagnosis (POCAD)™ solution is transforming the medical ultrasound industry, announced its seed funding round today. The company secured $13 million, led by Harel Insurance Investments & Financial Services Ltd. and Shoni Top Ventures, L.P.

Key Points: 
  • AISAP's POCAD™ solution solves this challenge by providing AI-powered diagnoses that are both highly accurate and easy for any physician to understand – not just ultrasound experts.
  • Unlike most other POCUS devices, AISAP's POCAD™ solution can even provide detailed, accurate diagnoses of specific valves within the cardiovascular systems.
  • And while the average ultrasound takes weeks on average to provide a full analysis and diagnosis, AISAP's solution does so in as little as 5 minutes.
  • In 29% of those cases, the AISAP solution discovered at least one previously-unknown, moderate medical condition.

AppliedXL Collaborates with Bloomberg to Provide AI-Powered, Real-Time Pharma News on the Bloomberg Terminal

Retrieved on: 
Thursday, May 2, 2024
Intelligence, Bloomberg, Workflow, Human, Bloomberg Terminal, Algorithm, Clinical trial, Artificial intelligence, News, AI

NEW YORK, May 2, 2024 /PRNewswire/ -- Today, AppliedXL announced a new collaboration with Bloomberg to deliver all Bloomberg Terminal users with key insights to help them get ahead of catalyst events in the pharmaceutical industry. AppliedXL's AI technology analyzes live public data to uncover signals and niche trends, distilling it into early news stories that Bloomberg will include in real-time news feeds used for early signal detection and market analysis.

Key Points: 
  • The first real-time news vertical that AppliedXL will make available on the Bloomberg Terminal covers the life sciences and biopharma space, encompassing public and private biotech and pharmaceutical companies.
  • Bloomberg Terminal users will be alerted to irregularities in clinical trial progressions and other events that may move the market.
  • "We're excited to empower Bloomberg Terminal users with AppliedXL's well-formulated, real-time news briefings that help them get ahead of the curve."
  • AppliedXL focuses on surfacing and distilling the highest quality of information rather than presenting users with an overwhelmingly comprehensive download.

UniDoc Health Corp. Unveils NEIL Connect®

Retrieved on: 
Thursday, May 2, 2024
HIPAA, Accountability Act, Hospital, Communication, UDOC, EHealth, Health information management, Patient, Privacy, Legislation, Data collection, Algorithm, FRA, Medical imaging

VANCOUVER, BC, May 2, 2024 /PRNewswire/ - UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) ("UniDoc," or the "Company"), an innovator in the eHealth sector, proudly announces the launch of its latest innovative software, NEIL Connect®.

Key Points: 
  • VANCOUVER, BC, May 2, 2024 /PRNewswire/ - UniDoc Health Corp. (CSE: UDOC) (FRA: L7T) (OTCQB: UDOCF) ("UniDoc," or the "Company"), an innovator in the eHealth sector, proudly announces the launch of its latest innovative software, NEIL Connect®.
  • NEIL Connect® integrates advanced AI with state-of-the-art diagnostic tools and communication technology, enhancing how doctors, clinicians, and patients connect and access high-quality care.
  • Incorporated into UniDoc's H3 Health Cube, NEIL Connect offers a HIPAA-compliant, customizable platform that synergizes patient and provider data, electronic health records, and various virtual modalities.
  • UniDoc CEO Antonio Baldassarre comments, "NEIL Connect® is more than just a technological advancement; it's an integrated development in eHealth.